Michael May
Endocrinology, Diabetes & Metabolism · Nashville, TNNPI 1629160056
Payments from drug & device makers
$688,576in general payments, 2019–2025
Across 1,931 payments — averaging $356.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$625K
- Sanofi US Services Inc.$63K
- Angiodynamics, Inc.$186
- Lifescan, Inc.$109
General payments by program year
19
22
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 1,918 | $625,354 |
| Sanofi US Services Inc. | 11 | $62,926 |
| Angiodynamics, Inc. | 1 | $186 |
| Lifescan, Inc. | 1 | $109 |
How this compares
$688,576 in reported general payments places this provider in the 90th percentile of 130 endocrinology, diabetes & metabolism providers in Tennessee.
See all endocrinology, diabetes & metabolism providers in Tennessee →
Other endocrinology, diabetes & metabolism in Nashville
- Stephen SharpNashville$25.9M
- Kathryn DahirNashville$11M
- Craig WierumNashville$1.7M
- Terri JerkinsNashville$1.2M
- Shichun BaoNashville$735K
- Michael CarlsonNashville$381K
- Rodney SnowNashville$188K
- Kevin NiswenderNashville$100K
- Howard BaumNashville$81K
- Annis MarneyNashville$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.